Radiopharmaceutical Space Rolling as Eli Lilly Acquires Point
Research - This morning, Eli Lilly (LLY) acquired Point Bio (PNT) for $12.50/share, an 87% premium. The $1.4B price tag gives Lilly a strong presence in radiopharmaceuticals … Continue Reading
Read now